Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
pH-Responsive cRGD-PEG-siRNA for Glioblastoma
2026-09-08
The 2024 Bioconjugate Chemistry study developed a pH-responsive cRGD-PEG-siEGFR conjugate designed to improve glioblastoma targeting, serum stability, circulation time, and renal safety relative to an earlier cRGD-siRNA format. Its experiments linked αvβ3-selective uptake in U87MG cells with EGFR silencing, antitumor activity, and reduced renal accumulation, while also defining important questions for translation beyond the reported models.
FPH1 (BRD-6125) Hepatocyte Assay Guide
2026-09-07
FPH1 (BRD-6125) helps pair hepatocyte expansion with functional readouts such as albumin, CYP3A4, AFP, nuclei count, and mitotic activity. This practical guide covers dosing, iPSC-derived hepatocyte workflows, troubleshooting, and a carefully bounded connection to light-controlled gene regulation.
Ac-YVAD-CMK for Kupffer Cell Pyroptosis Assays
2026-09-07
Ac-YVAD-CMK helps separate caspase-1-dependent cytokine maturation from upstream membrane injury in Kupffer cell inflammation models. This workflow translates TMEM16F–Listeria findings into practical controls for measuring pyroptosis, IL-1β/IL-18 release, and liver-cell damage.
NLRP10, Keratinocyte Survival, and Skin Barrier Function
2026-09-05
The reference study identifies NLRP10 as a functional regulator of epidermal homeostasis, extending its association with atopic dermatitis beyond genetics to keratinocyte survival, p63-dependent differentiation, and barrier integrity. Its human skin-equivalent model and mechanistic analysis position NLRP10 as a candidate pathway for studying how impaired cell survival and differentiation contribute to atopic dermatitis.
Western Secondary Antibody Dilution Buffer Guide
2026-09-04
Western Secondary Antibody Dilution Buffer K4115 is formulated to support consistent secondary-antibody dilution, reduce non-specific antibody binding, and improve antibody stability in assays. Its product-reported reuse, storage, and volume specifications can help standardize protein detection Western blot workflows without changing the underlying biology measured.
Arachidonic Acid for Immune Assay Workflows
2026-09-04
A practical guide to using Arachidonic Acid as a controllable substrate for immune, inflammation, and eicosanoid-biosynthesis experiments. The workflow emphasizes solvent control, oxidation management, pathway-resolved readouts, and translation of recent vaccine-immunity findings into bench assays.
Amyloid Beta-Peptide (1-40): Assay Workflows
2026-09-03
Build more reproducible Alzheimer’s disease experiments by controlling Aβ40 concentration, assembly state, storage, and exposure time. This workflow positions the peptide for parallel fibril-formation, neuronal toxicity, calcium-signaling, and microglial immune-regulation assays.
Lenalidomide (CC-5013) in Myeloma Research
2026-09-03
Lenalidomide (CC-5013) combines immune remodeling, TNF-alpha suppression, and anti-angiogenic activity in versatile hematologic cancer assays. This workflow shows how to test its multiple myeloma activity alone or alongside DOT1L inhibition while preserving solvent control, mechanistic readouts, and reproducibility.
Abiraterone Acetate in Patient-Derived 3D Models
2026-09-02
Discover how Abiraterone acetate can be evaluated as a CYP17 inhibitor in patient-derived prostate spheroids. This evidence-led guide connects steroid biology, model quality, and assay interpretation while distinguishing organ-confined disease models from CRPC research.
Lanabecestat (AZD3293) Assay Workflow
2026-09-02
A scenario-based guide to using Lanabecestat (AZD3293), SKU BA8438, in Alzheimer’s disease research and cell-based viability, proliferation, and cytotoxicity workflows. It connects BACE1 potency, amyloid-beta measurements, vehicle controls, synaptic-function assays, and practical product-selection decisions to improve interpretation and reproducibility.
iPSC Organoids Reveal Pan-Tissue HEV Infection
2026-09-01
This reference study establishes multilineage iPSC-derived liver, intestinal and brain organoids that support complete propagation of wild-type HEV genotypes 1, 3 and 4. The models resolve tissue-specific viral tropism, injury responses and partial ribavirin rescue, offering a physiologically relevant platform for host–pathogen research and antiviral evaluation.
T0070907 as a PPARγ Pathway Counterprobe
2026-09-01
T0070907 is a high-affinity PPARγ antagonist for separating receptor-dependent transcription from broader cellular effects. This article shows how to apply it as a mechanistic counterprobe when studying the RXRα/PPARγ/NEDD4 axis and SASP-associated inflammation.
Mitochondrial Repair in Diabetic Periodontitis
2026-08-31
The reference study develops a hierarchically targeted, ROS-responsive hydrogel platform designed to repair mitochondrial dysfunction in M1 macrophages during diabetic periodontitis. By combining tuftsin-functionalized MitoQ-loaded nanoparticles with a ROS-cleavable PVA hydrogel, the approach suppresses inflammasome-associated inflammation and improves periodontal bone regeneration in a diabetic rat model.
Fludarabine in Neoantigen Immunotherapy Workflows
2026-08-31
Learn how Fludarabine can support controlled DNA-damage, cell-cycle, and apoptosis studies while informing lymphodepletion-inspired immunotherapy experiments. This workflow-focused guide connects leukemia and multiple myeloma models with practical antigen-presentation and T-cell co-culture assays.
Protease Inhibitor Cocktail: Practical Use Guide
2026-08-30
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) helps limit proteolytic damage during protein extraction and downstream analysis, including Western blotting, co-immunoprecipitation, and phosphorylation-sensitive assays. Its EDTA-free composition is useful when divalent cations must remain available, but protocols that depend on EDTA, are sensitive to DMSO, or require uninhibited enzyme activity need separate compatibility testing.
7947 records 7/530 page Previous Next First page 上5页 678910 下5页 Last page